Published on in Vol 8 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/66031, first published .
Sarcopenia and Risk of Cognitive Impairment: Cohort Study and Mendelian Randomization Analysis

Sarcopenia and Risk of Cognitive Impairment: Cohort Study and Mendelian Randomization Analysis

Sarcopenia and Risk of Cognitive Impairment: Cohort Study and Mendelian Randomization Analysis

Journals

  1. Zhou Y, Guo X, Dong S, Wang C, Wu L, Liu W. Causal relationship between sarcopenia and cognitive performance: A bidirectional Mendelian randomization study. Medicine 2025;104(45):e45718 View
  2. Kilaitė J, Pranckevičienė E, Ginevičienė V, Urnikytė A, Dadelienė R, Mastavičiūtė A, Jamontaitė I, Alekna V, Ahmetov I. Causal relationships between sarcopenia, frailty, and health outcomes: A systematic review of Mendelian randomization studies. Experimental Gerontology 2025;212:112953 View
  3. Araújo L, Figueiredo Godoy A, Fortes Frota F, Barbalho Lamas C, Quesada K, Rucco Penteado Detregiachi C, Cressoni Araújo A, Miglino M, Landgraf Guiguer E, Santos de Argollo Haber R, de Souza Bastos Mazuqueli Pereira E, Cavallari Strozze Catharin V, Cavallari Strozze Catharin V, Laurindo L, Maria Barbalho S. Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches. International Journal of Molecular Sciences 2025;26(24):12147 View
  4. Luo C, Wu H, Shen X, Han S, Lin L, Liu B. Transitions in Sarcopenia Status and Cognitive Trajectories Among Middle-Aged and Older Adults in China: Longitudinal Cohort Study. JMIR Aging 2025;8:e78277 View